Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risks of Opioids in ST-Elevation Myocardial Infarction: A Review.
Tavenier AH, Hermanides RS, Ottervanger JP, Ter Horst PGJ, Kedhi E, van 't Hof AWJ. Tavenier AH, et al. Among authors: kedhi e. Drug Saf. 2018 Dec;41(12):1303-1308. doi: 10.1007/s40264-018-0710-y. Drug Saf. 2018. PMID: 30155802 Review.
Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
Roolvink V, Rasoul S, Ottervanger JP, Dambrink JH, Lipsic E, van der Horst IC, de Smet B, Kedhi E, Marcel Gosselink AT, Piek JJ, Sanchez-Brunete V, Ibanez B, Fuster V, Van't Hof AW; EARLY-BAMI investigators. Roolvink V, et al. Among authors: kedhi e. Am Heart J. 2014 Nov;168(5):661-6. doi: 10.1016/j.ahj.2014.07.015. Epub 2014 Jul 28. Am Heart J. 2014. PMID: 25440793 Clinical Trial.
Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
Roolvink V, Ibáñez B, Ottervanger JP, Pizarro G, van Royen N, Mateos A, Dambrink JE, Escalera N, Lipsic E, Albarran A, Fernández-Ortiz A, Fernández-Avilés F, Goicolea J, Botas J, Remkes W, Hernandez-Jaras V, Kedhi E, Zamorano JL, Navarro F, Alfonso F, García-Lledó A, Alonso J, van Leeuwen M, Nijveldt R, Postma S, Kolkman E, Gosselink M, de Smet B, Rasoul S, Piek JJ, Fuster V, van 't Hof AWJ; EARLY-BAMI Investigators. Roolvink V, et al. Among authors: kedhi e. J Am Coll Cardiol. 2016 Jun 14;67(23):2705-2715. doi: 10.1016/j.jacc.2016.03.522. Epub 2016 Apr 3. J Am Coll Cardiol. 2016. PMID: 27050189 Free article. Clinical Trial.
Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus.
Kennedy MW, Kaplan E, Hermanides RS, Fabris E, Hemradj V, Koopmans PC, Dambrink JH, Marcel Gosselink AT, Van't Hof AW, Ottervanger JP, Roolvink V, Remkes WS, van der Sluis A, Suryapranata H, Kedhi E. Kennedy MW, et al. Among authors: kedhi e. Cardiovasc Diabetol. 2016 Jul 19;15:100. doi: 10.1186/s12933-016-0417-2. Cardiovasc Diabetol. 2016. PMID: 27431395 Free PMC article.
Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus.
Kennedy MW, Hermanides RS, Kaplan E, Hemradj V, Fabris E, Koopmans PC, Dambrink JE, Gosselink AT, Van't Hof AW, Ottervanger JP, Roolvink V, Remkes WS, van der Sluis A, Suryapranata H, Kedhi E. Kennedy MW, et al. Among authors: kedhi e. Am J Cardiol. 2016 Nov 1;118(9):1293-1299. doi: 10.1016/j.amjcard.2016.07.059. Epub 2016 Aug 13. Am J Cardiol. 2016. PMID: 27614852 Free article.
Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT-FFR) prospective study. Rationale and design.
Kennedy MW, Fabris E, Ijsselmuiden AJ, Nef H, Reith S, Escaned J, Alfonso F, van Royen N, Wojakowski W, Witkowski A, Indolfi C, Ottervanger JP, Suryapranata H, Kedhi E. Kennedy MW, et al. Among authors: kedhi e. Cardiovasc Diabetol. 2016 Oct 10;15(1):144. doi: 10.1186/s12933-016-0464-8. Cardiovasc Diabetol. 2016. PMID: 27724869 Free PMC article.
Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
Schellings DA, Adiyaman A, Dambrink JE, Gosselink AM, Kedhi E, Roolvink V, Ottervanger JP, Van't Hof AW. Schellings DA, et al. Among authors: kedhi e. Vasc Health Risk Manag. 2016 Nov 21;12:471-476. doi: 10.2147/VHRM.S117204. eCollection 2016. Vasc Health Risk Manag. 2016. PMID: 27920547 Free PMC article.
145 results